ER-positive and BRCA2-mutated breast cancer: a literature review
European Journal of Medical Research（2024）
Abstract
BRCA2-mutated carriers have a high lifetime risk of breast cancer (BC), an early age of onset, and an increased risk of other cancers (including ovarian, pancreatic, and prostate cancer). Almost 70–80
MoreTranslated text
Key words
Breast cancer,BRCA2 mutation,ER-positive,PARP inhibitor,CDK4/6 inhibitor,Survival rate
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined